Red Clover Isoflavones as Effective Longevity Agents for Anti-Aging and Regenerative Skin Applications
Type
Journal article
Language
English
Date issued
2026
Author
Gościniak, Anna
Bogusławska, Klaudyna
Szymańska, Małgorzata
Kaproń-Plech, Barbara
Trzaskoma, Piotr
Cielecka-Piontek, Judyta
Faculty
Wydział Rolnictwa, Ogrodnictwa i Biotechnologii
Journal
Plants
ISSN
2223-7747
Web address
Volume
15
Number
4
Pages from-to
art. 553
Abstract (EN)
Red clover (Trifolium pratense L.) is a rich source of isoflavones with documented antioxidant and skin-protective properties, yet substantial differences in phytochemical composition exist among cultivars. In this study, fourteen T. pratense cultivars were compared with respect to formononetin and biochanin A contents (Milena, Pasieka, Pyza, Milvus, Nemaro, Maro, Larus, Hammon, Vesna, Fregata, Carbo, Forelia, Osimia, and Elanus), and the relationship between isoflavone profiles and skin-related biological activity was evaluated. High-performance liquid chromatography revealed pronounced cultivar-dependent variability with formononetin and biochanin A contents ranging from 1.60 to 7.80 mg/g DW and from 0.69 to 6.44 mg/g DW, respectively. The observed variability was further visualized by principal component analysis. The cultivar with the highest total isoflavone content—Hammon, was selected for biological assessment. Its extract exhibited antioxidant (DPPH IC50 = 0.619 mg/mL; FRAP IC0.5 = 0.302 mg/mL) and enzyme inhibitory activities (elastase IC50 = 0.602 mg/mL, hyaluronidase IC50 = 22.44 mg/mL), and it significantly enhanced fibroblast migration in an in vitro scratch assay, indicating anti-aging and regenerative potential. These results demonstrate that red clover cultivars differ significantly in their suitability as sources of bioactive isoflavones and highlight the importance of cultivar selection for the development of standardized plant-derived anti-aging ingredients. However, it is worth emphasizing that isoflavones derived from red clover are a valuable group of active compounds with significant potential for topical application as anti-aging and regenerative agents, warranting further formulation development and in vivo validation.
License
CC-BY - Attribution
Open access date
February 10, 2026